Morningstar19d
Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report– Hagens Berman
Regeneron Pharmaceuticals, Inc. (REGN) Securities Class Action: The litigation is focused on the propriety of Regeneron’s statements about its compliance with applicable rules and regulations ...
Telegram19d
Uxbridge school chief on leave after drunken driving arrest; interim superintendent named
UXBRIDGE ― Uxbridge Superintendent Michael Baldassarre was placed on paid administrative leave and an interim superintendent was named during a School Committee meeting Tuesday night ...
MassLive20d
Uxbridge school superintendent on leave in connection with OUI, report says
The superintendent of Uxbridge Public Schools is on paid administrative leave as of Tuesday night in connection with an arrest stemming from an OUI incident last week, the Telegram & Gazette reported.
ENDPOINTS NEWS20d
'No mir­a­cles': What Re­gen­eron's George Yan­copou­los re­al­ly thinks of AI
SAN FRAN­CIS­CO — Just over 20 years ago, the peo­ple of Cal­i­for­nia vot­ed to spend bil­lions of dol­lars on an ex­cit­ing new idea to re­make med­i­cine … ...
Morningstar20d
Shareholders that lost money on Regeneron Pharmaceuticals, Inc.(REGN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities ...
Boston.com20d
Uxbridge schools superintendent on leave after being charged with drinking and driving
The superintendent of Uxbridge Public Schools appeared in court Tuesday after he was arrested for allegedly driving while intoxicated over the weekend, according to court records. Michael ...
Pharmaceutical Technology20d
Fianlimab by Regeneron Pharmaceuticals for Lymphoma: Likelihood of Approval
Fianlimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase I for Lymphoma. According to GlobalData, Phase I drugs for Lymphoma have a 66% phase transition success rate ...
The Boston Globe20d
Uxbridge schools superintendent charged with OUI, was allegedly driving 100 miles per hour on I-495, police say
The superintendent of Uxbridge public schools has been placed on leave, the town’s school committee announced Tuesday night, hours after he was arraigned on a drunken driving charge for ...
Yahoo Finance20d
REGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS FIRST HEADQUARTERS TO BETTER SERVE NEEDS OF CANADIANS WITH SERIOUS DISEASES
Facilities for Regeneron Canada in thriving Mississauga/GTA biotech hub signal its growth and readiness to bring more of its life-transforming innovative medicines for serious diseases to ...
Telegram20d
Uxbridge Superintendent Michael Baldassarre arrested on drunken driving charge
UXBRIDGE — Uxbridge Superintendent Michael Baldassarre is facing a drunken driving charge after police allege he drove 100 mph and nearly caused a crash on Interstate 495 in Bolton over the ...
MassLive21d
Uxbridge Public Schools superintendent charged with OUI
Michael Baldassarre, the superintendent for Uxbridge Public Schools, was released on personal recognizance Tuesday after he was charged with driving while under the influence on Saturday.
Pharmaceutical Technology21d
Trevogrumab by Regeneron Pharmaceuticals for Obesity: Likelihood of Approval
Trevogrumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success ...